About Nimble Science
Nimble Science is a company based in Calgary (Canada) founded in 2018 by Sabina Bruehlmann and Joseph Wang. Nimble Science has raised $2.7 million across 1 funding round from investors including University of Calgary, Fusion Fund and First Spark Ventures. Nimble Science offers products and services including SIMBA GI Platform, Biopharma Services, and Nutrition Services. Nimble Science operates in a competitive market with competitors including Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others.
- Headquarter Calgary, Canada
- Founders Sabina Bruehlmann, Joseph Wang
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.7 M (USD)
in 1 rounds
-
Latest Funding Round
$2.7 M (USD), Seed
Apr 04, 2023
-
Investors
University of Calgary
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nimble Science
Nimble Science offers a comprehensive portfolio of products and services, including SIMBA GI Platform, Biopharma Services, and Nutrition Services.
Autonomous capsule for collecting multi-omic data from small intestine.
Partnerships for biopharma and nutrition data analysis.
Support for validating microbiome changes in nutrition.
People of Nimble Science
Unlock access to complete
Software Development Team
2 people
Leadership Team
1 people
Data Analysis and Operations Team
1 people
Unlock access to complete
Funding Insights of Nimble Science
Nimble Science has successfully raised a total of $2.7M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.7 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nimble Science
Nimble Science has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Calgary, Fusion Fund and First Spark Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in early-stage startups focusing on healthcare, AI, and industrial technology.
|
Locked | Locked | Locked | |
|
A venture capital fund focused on deep tech innovations is managed.
|
Locked | Locked | Locked | |
|
Venture capital investing and portfolio management services for accredited investors.
|
Locked | Locked | Locked |
Investor details for Nimble Science
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nimble Science
Investment portfolio details for Nimble Science
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nimble Science
Detailed financials for Nimble Science
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nimble Science Comparisons
Peer comparison for Nimble Science
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nimble Science
Nimble Science operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| Locked | Locked | Locked |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| Locked | Locked | Locked |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
|
| Locked | Locked | Locked |
Diagnostic services are provided through laboratories and radiology units.
|
Detailed competitors of Nimble Science
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nimble Science
Complete news archive for Nimble Science
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nimble Science
Nimble Science was founded in 2018 and raised its 1st funding round 5 years after it was founded.
Nimble Science is headquartered in Calgary, Canada. It is registered at Calgary, Alberta, Canada.
Sabina Bruehlmann is the current CEO of Nimble Science. They have also founded this company.
Nimble Science is a funded company, having raised a total of $2.7M across 1 funding round to date.
Nimble Science was founded in 2018 in Calgary, Canada. Operations center on biotechnology for gut health, where probiotic-based medicines, novel capsules, and small intestine sampling tools are developed. Gut microorganisms are sequenced and mapped, while biomarkers are collected to enable personalised treatments. Diagnostic innovations are also pursued to support microbiome analysis in the healthcare sector.
Nimble Science's top competitors include Juno Therapeutics, Poseida Therapeutics and Denali Therapeutics.
Nimble Science offers SIMBA GI Platform, Biopharma Services, and Nutrition Services.
Nimble Science has 11 investors. Key investors include University of Calgary, Fusion Fund, First Spark Ventures, Alumni Ventures, and Joyance Partners.